BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33554592)

  • 1. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
    Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
    Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Structure and Cytotoxicity of N,N and N,O-Coordinated Ru
    Mukherjee A; Koley TS; Chakraborty A; Purkait K; Mukherjee A
    Chem Asian J; 2021 Nov; 16(22):3729-3742. PubMed ID: 34549886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
    Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
    Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Structure, Stability, and Inhibition of Tubulin Polymerization by Ru
    Acharya S; Maji M; Ruturaj ; Purkait K; Gupta A; Mukherjee A
    Inorg Chem; 2019 Jul; 58(14):9213-9224. PubMed ID: 31241921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic Ru
    Sarkar A; Acharya S; Khushvant K; Purkait K; Mukherjee A
    Dalton Trans; 2019 May; 48(21):7187-7197. PubMed ID: 30601545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II)
    Maji M; Acharya S; Bhattacharya I; Gupta A; Mukherjee A
    Inorg Chem; 2021 Apr; 60(7):4744-4754. PubMed ID: 33760599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Half-Sandwich Ru(
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Fernandes AR; Roma-Rodrigues C; Teixeira RG; Marques F; Folgueira M; Yáñez J; Gonzalez AA; Salamini-Montemurri M; Pech-Puch D; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Inorg Chem; 2021 Mar; 60(5):2914-2930. PubMed ID: 33570919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.
    Eslami Moghadam M; Hasanzadeh Esfahani M; Behzad M; Zolghadri S; Ramezani N; Azadi Y
    J Biol Inorg Chem; 2023 Aug; 28(5):519-529. PubMed ID: 37452868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation.
    Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA
    Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
    Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
    Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells.
    Pavlović M; Tadić A; Gligorijević N; Poljarević J; Petrović T; Dojčinović B; Savić A; Radulović S; Grgurić-Šipka S; Aranđelović S
    J Inorg Biochem; 2020 Sep; 210():111155. PubMed ID: 32768729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor selective Ru(III) Schiff bases complexes with strong in vitro activity toward cisplatin-resistant MDA-MB-231 breast cancer cells.
    Pavlović M; Kahrović E; Aranđelović S; Radulović S; Ilich PP; Grgurić-Šipka S; Ljubijankić N; Žilić D; Jurec J
    J Biol Inorg Chem; 2023 Apr; 28(3):263-284. PubMed ID: 36781474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
    Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
    J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.